SUPPLEMENTARY METHODS
For verification of specific results we performed reverse transcription (RT) using random hexamers and SSII reverse transcriptase (Invitrogen), after which real-time quantitative (q)PCR analysis was performed using gene-specific primer pairs ( Supplementary Table 3 ).
For parametric analysis of gene set enrichment (PAGE), a set of 1687 pathways was obtained from http://www.broad.mit.edu/gsea/msigdb/msigdb_index.html (C2 collection). Our expression data was tested for gene set enrichment using the PAGE method as previously Illumina mouseRef-8 v1.1 platforms. Expression data from both platforms was normalized using Z-score transformation and the significance of treatment differences was evaluated using the Zratio test method that has been previously described 2 . Based upon this method, a total of 251, 281, 67 and 223 transcripts were significantly up regulated by 30 mg/kg SRT1720, 100 mg/kg SRT1720, low resveratrol and high resveratrol, respectively (P < 0.05). Likewise, a total of 310, 309, 96 and 239 transcripts were significantly down regulated by 30 mg/kg SRT1720, 100 mg/kg SRT1720, low resveratrol and high resveratrol, respectively (P < 0.05).
Some differentially expressed transcripts were not included among the 16075 transcripts that are shared between the Illumina MouseRef-8 v2.0 and Illumina mouseRef-8 v1.1 beadchips. With respect to such transcripts, it was not possible to make comparisons between the effects of SRT1720 and resveratrol. Among the 16075 transcripts that were comparable between platforms, a total of 168, 181, 58 and 181 were up regulated by 30 mg/kg SRT1720, 100 mg/kg SRT1720, low resveratrol and high resveratrol, respectively (P < 0.05).
Likewise, among these 16075 transcripts, 184, 181, 70 and 163 were down regulated by 30 mg/kg SRT1720, 100 mg/kg SRT1720, low resveratrol and high resveratrol, respectively (P < 0.05).
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The association between resveratrol and SRT1720 was evaluated based upon four pairwise comparisons of transcriptional patterns (low resveratrol vs. 30 mg/kg SRT1720; high resveratrol vs. 30 mg/kg SRT1720; low resveratrol vs. 100 mg/kg SRT1720; high resveratrol vs.
100 mg/kg SRT1720). For each comparison, differential expression signatures corresponding to the respective effects of resveratrol and SRT1720 were constructed, and based upon crosstabulation of these signatures, we evaluated evidence for a non-random association between SRT1720-and resveratrol-associated differential expression patterns ( Supplementary Fig. 5 ).
Cell culture, survival and mitochondrial biogenesis
Primary MEFs in which SIRT1 had been inactivated via exon deletion were a kind gift from Raul Mostoslavsky. MEFs were immortalized in culture using a standard 3T3 protocol 3 .
Immortalized MEFs were maintained in DMEM medium (4.5g glucose / L) supplemented with 10% fetal bovine serum (FBS) and 100 μg/ml penicillin/streptomycin and cells were not grown to higher than 80% confluency.
For SRT1720 treatments, the compound was dissolved in DMSO and the final concentration of DMSO was 0.6% or less for all treatments. The MTT assay was used for cell survival assessment as a putative marker of mitochondrial activity based on the reduction of the tetrazolium salt MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide) into a blue formazan product by the mitochondrial enzyme succinate dehydrogenase 4 . MEFs were pretreated with SRT1720 for 24h and 500 μM H 2 O 2 was then added to the cells. After incubation for 24h at 37°C, cell survival was determined.
In vitro Sirt1 deacetylase activity
Recombinant full-length human His-tagged Sirt1 was produced in BL21(DE3) pLysS bacteria, and purified as previously described for dSir2 5 Hazard Function Total cholesterol (c) is elevated in all high fat groups compared with SD (n = 6; age = 82 wks; diet = 26 wks). DNA fragmentation (d), an indication of cellular apoptosis, is elevated in HFD mice only and is significantly lowered in HFD-H compared with HFD. The increase in transcript levels of inflammatory markers (e) by HFD is attenuated by treatment with SRT1720.
Isoprostane levels (f), markers of oxidative stress, are increased in the HFD group compared with SD but not in the groups supplemented with SRT1720 (n = 6; age = 82 wks; diet = 26 wks). Data are represented as the mean ± SEM. *P < 0.0083 from SD; † P < 0.0083 from HFD.
Supplementary Figure 4
Metabolic and physical activity response to SRT1720. Oxygen consumption (a) but not carbon dioxide output (b) is dysregulated in the HFD mice during the light cycle (n = 14 (SD), 12 (HFD), 10 (HFD-L), 14 (HFD-H); age = 122 wks; diet = 66 wks). The respiratory exchange ratio (RER) is reduced in all HFD groups compared with SD (c). Reduced locomotor activity associated with the HFD is prevented by SRT1720 (d) in the inclined screen test (n = 9; age = 69 wks; diet = 13 wks). Data are represented as the mean ± SEM. *P < 0.0083 from SD. Supplementary Table 3a Major pathologies at 82 weeks of age as determined by blinded histopathological analysis.
The percentage of mice developing various pathologies is represented in most cases, with glomerulonephritis representing an average score in a range of 0-4, with 4 being the most severe. Overall there was no major effect due to SRT1720 on pathology at this time point.
Diet Treatment (n)

SD (6) HFD (6) HFD-L (6) HFD-H (6)
Heart RNA from all animals in each group was pooled and amplified using primers specific for the indicated targets. M denotes fold changes obtained from the microarray analysis while PCR denotes values obtained by RT-PCR. Supplementary Table 4f Genes upregulated by SRT1720 and/or resveratrol in liver.
Fold Change
HFD vs SD HFD-L vs HFD HFD-H vs HFD
The table lists genes for which expression was increased in four comparisons (red cells), increased in three comparisons (orange cells), or increased in two comparisons (yellow cells). Values in the table list the fold-change estimate associated with each transcript, i.e., expression in the experimental treatment relative to the control. P-values listed in parentheses were obtained from the Z-ratio test procedure as previously described 2 . The value "NS" is used to indicate transcripts for which the experimental treatment had no significant effect on gene expression (P > 0.05). 
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